Valeritas (NSDQ:VLRX) said today that it signed an exclusive distribution deal with Med Trust to commercialize its V-Go insulin delivery device in Austria and Germany.
According to the terms of the agreement, Valeritas will be responsible for product development, regulatory approval, quality management and manufacturing. Med Trust will take over the sales, marketing and distribution activities related to the V-Go wearable device in Austria and Germany, the companies reported.
Get the full story at our sister site, Drug Delivery News.
The post Valeritas inks distro deal for V-Go device in Austria, Germany appeared first on MassDevice.
from MassDevice https://ift.tt/2IA3ELX
Cap comentari:
Publica un comentari a l'entrada